Pearl Health
Pearl Health develops a platform for primary care physicians, featuring fixed payments and analytics to support value-based patient care.
Secondary Market Price
Secondary Market Price
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Pearl Health's value.
Sign up to Unlock the Latest DataProspect Projected Future Pearl Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Pearl Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Pearl Health is a healthcare technology company that operates a care-delivery and billing platform for primary care physicians. The platform supports doctors participating in value-based care models by providing fixed, per-member-per-month payments for their traditional Medicare patients. It also offers clinical insights through data analytics and practice performance services, which helps reduce administrative tasks so physicians can focus on patient care. The company was founded in 2020 in New York, New York, by Michael Kopko, Kevin Ryan, and Jeffrey Flavio and has since grown to a team of 100-250 employees.
Looking forward, Pearl Health plans to expand into the Medicare Advantage market, invest in research and development, and grow its ecosystem of specialty care partners. The company has seen significant recent momentum, including a $75 million Series B funding round in January 2023 led by Andreessen Horowitz and Viking Global, which resulted in a valuation of approximately $300 million. In late 2023, Pearl Health also formed a strategic partnership with Walgreens to accelerate the adoption of value-based care among primary care providers.
- Andreessen Horowitz
- SV Angel
- Viking Global
- Co-Founder, CEO Michael Kopko
- Co-Founder, Executive Chairman Jeffrey De Flavio
- Co-Founder, President Ankit Patel
Peer Group Comparison
Vs Peer Group of >$4B Startups
How Pearl Health Measures Up
To help you manage your Pearl Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
3X
Our rating indicates Pearl Health could be worth 3X its current value within four years. For employees with an equity package, this suggests your stock could triple in value.
Exit Risk
Moderate Risk
Our 'Moderate Risk' rating for Pearl Health reflects a moderate likelihood that the company will not reach a liquidity event for its employees when compared to other startups.
Funding Stage
Series B
A Series B company like Pearl Health has moved past the initial startup phase and is now focused on scaling its proven model. This means you have the opportunity to join a growing team with more structure than an early-stage venture but still plenty of room to make a significant impact.
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Pearl Health worth joining?
Pearl Health is a well-funded, early-stage healthcare technology company backed by top-tier investors like Andreessen Horowitz and has a strategic partnership with Walgreens. To determine if it's the right fit for you, you can use a platform like Prospect to analyze its equity potential and compare it with other startup opportunities.
What should I do with my Pearl Health stock?
As Pearl Health is a private company, your options typically include holding your shares or exploring a sale on a secondary market, if available. Tools like Prospect can help you model different scenarios, understand tax implications, and create a personalized strategy for your equity.
Can you sell Pearl Health stock?
Because Pearl Health is a private, pre-IPO company, its stock is not traded on public exchanges like the NYSE or NASDAQ. However, employees and early investors can sometimes sell shares on secondary markets, and platforms like Prospect offer tools and data to help navigate these private transactions.
How can I find the value of my Pearl Health stock?
Pearl Health's latest valuation was approximately $300 million following its Series B funding round in January 2023. For ongoing valuation estimates, you can use a platform like Prospect, which analyzes company data and market trends to project the value of private company equity.
What is Pearl Health's equity worth?
The company was valued at around $300 million during its most recent funding round. The specific worth of your personal equity stake depends on factors like share count and tax implications, which can be analyzed using equity management tools.
What is Pearl Health's stock ticker symbol?
Pearl Health does not have a stock ticker symbol because it is a private company and its shares are not available on public stock exchanges. Ticker symbols are used to identify publicly traded companies, a stage Pearl Health has not yet reached.
Can I buy or sell Pearl Health stock?
As a private company, buying shares in Pearl Health is generally restricted to accredited investors and institutions participating in official funding rounds. Existing shareholders may be able to sell their stock on secondary markets, and platforms like Prospect provide data and tools to help manage such transactions.
What is the criteria to buy or invest in Pearl Health stock?
Investment in Pearl Health is typically limited to institutional venture capital firms and accredited investors who are invited to participate in private funding rounds. The company is currently at the Series B stage and has not made its shares available for purchase by the general public.
